​

Verve Therapeutics (VERV) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Verve Therapeutics Revenue Highlights

Latest Revenue (Y)

$32.33M

Latest Revenue (Q)

$13.08M

Verve Therapeutics Revenue by Period

Verve Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$32.33M174.98%
2023-12-31$11.76M505.77%
2022-12-31$1.94M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Verve Therapeutics generated $32.33M in revenue during NA 2024, up 174.98% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Verve Therapeutics Revenue by Quarter

DateRevenueChange
2024-12-31$13.08M90.53%
2024-09-30$6.87M2.59%
2024-06-30$6.69M17.51%
2024-03-31$5.70M10.71%
2023-12-31$5.14M65.03%
2023-09-30$3.12M48.92%
2023-06-30$2.09M49.07%
2023-03-31$1.40M38.74%
2022-12-31$1.01M8.93%
2022-09-30$929.00K100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Verve Therapeutics generated $13.08M in revenue during Q4 2024, up 90.53% compared to the previous quarter, and up 419.63% compared to the same period a year ago.

Verve Therapeutics Revenue Breakdown

Verve Therapeutics Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceMar 25
Operating Segments$32.98M

Verve Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Operating Segments (100.00%).

Verve Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BPMCBlueprint Medicines$508.82M$149.41M
ADPTAdaptive Bio$178.96M$52.44M
CRSPCRISPR Therapeutics$37.31M$35.00M
VERVVerve Therapeutics$32.33M$13.08M
RLAYRelay Therapeutics$10.01M$7.68M
IPSCCentury Therapeutics$6.59M$109.16M
PRMEPrime Medicine$2.98M$2.18M
NTLAIntellia Therapeutics-$12.87M
EDITEditas Medicine--
SANASana Bio--
CRBUCaribou Biosciences-$2.08M
BEAMBeam Therapeutics-$30.07M

VERV Revenue FAQ

What is Verve Therapeutics’s yearly revenue?

Verve Therapeutics's yearly revenue for 2024 was $32.33M, representing an increase of 174.98% compared to 2023. The company's yearly revenue for 2023 was $11.76M, representing an increase of 505.77% compared to 2022. VERV's yearly revenue for 2022 was $1.94M, representing an increase of 100.00% compared to 2021.

What is Verve Therapeutics’s quarterly revenue?

Verve Therapeutics's quarterly revenue for Q4 2024 was $13.08M, a 90.53% increase from the previous quarter (Q3 2024), and a 154.28% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $6.86M, a 2.59% increase from the previous quarter (Q2 2024), and a 120.24% increase year-over-year (Q3 2023). VERV's quarterly revenue for Q2 2024 was $6.69M, a 17.51% increase from the previous quarter (Q1 2024), and a 219.73% increase year-over-year (Q2 2023).

What is Verve Therapeutics’s revenue growth rate?

Verve Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 1565.74%, and for the last 5 years (2020-2024) was 0%.